Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun Young Im

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Medicinal Chemistry|October 24, 2024
Structurally Minimalized and Druglike TGase2 Inhibitors Based on 7-Aminoquinoline-5,8-dione Scaffolds for the Treatment of Diabetic RetinopathyJihee Kang, Hye-Yoon Jeon, Jieon Lee, et al.
Molecular Cancer|April 14, 2025
KF1601, a dual inhibitor of BCR::ABL1 and FLT3, overcomes drug resistance in FLT3<sup>+</sup> blast phase chronic myeloid leukemiaHyun-Jin Kwon, Ji Eun Shin, Amir Khan, et al.
European Journal of Medicinal Chemistry|May 29, 2016
Synthesis and biological evaluation of novel 4-hydroxytamoxifen analogs as estrogen-related receptor gamma inverse agonistsJina Kim, Jungwook Chin, Chun Young Im, et al.
Journal of Medicinal Chemistry|November 3, 2016
Insights of a Lead Optimization Study and Biological Evaluation of Novel 4-Hydroxytamoxifen Analogs as Estrogen-Related Receptor γ (ERRγ) Inverse AgonistsJina Kim, Seo Yeon Woo, Chun Young Im, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Medicinal Chemistry|October 24, 2024
Structurally Minimalized and Druglike TGase2 Inhibitors Based on 7-Aminoquinoline-5,8-dione Scaffolds for the Treatment of Diabetic RetinopathyJihee Kang, Hye-Yoon Jeon, Jieon Lee, et al.
Molecular Cancer|April 14, 2025
KF1601, a dual inhibitor of BCR::ABL1 and FLT3, overcomes drug resistance in FLT3<sup>+</sup> blast phase chronic myeloid leukemiaHyun-Jin Kwon, Ji Eun Shin, Amir Khan, et al.
European Journal of Medicinal Chemistry|May 29, 2016
Synthesis and biological evaluation of novel 4-hydroxytamoxifen analogs as estrogen-related receptor gamma inverse agonistsJina Kim, Jungwook Chin, Chun Young Im, et al.
Journal of Medicinal Chemistry|November 3, 2016
Insights of a Lead Optimization Study and Biological Evaluation of Novel 4-Hydroxytamoxifen Analogs as Estrogen-Related Receptor γ (ERRγ) Inverse AgonistsJina Kim, Seo Yeon Woo, Chun Young Im, et al.
Pageof 2